Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
series A
Biotech
Ottimo raises $140M to ready PD1/VEGFR2 antibody for clinic
Two months after former Seagen CEO David Epstein unveiled his new project, the biotech has secured $140 million in series A funds.
James Waldron
Dec 19, 2024 6:58am
Fluid Biomed raises $27M for its bioabsorbable aneurysm stent
Dec 16, 2024 11:00am
Antag secures $84M series A for GLP-1 add-on
Dec 4, 2024 3:00am
Trace uses $101M series A to go after same ALS target as Lilly
Nov 12, 2024 7:00am
Horizon Surgical claims $30M for robotic cataract surgery
Oct 21, 2024 11:30am
Judo throws down $100M to knock out kidney disease
Oct 7, 2024 10:42am
